Nanobiotix is trading at $26.82, up 11.1% on October 21, 2026, with broader biotech strength the clearest available context; no company-specific catalyst was identified.
- The XBI rose 2.10% during the regular session amid biotech deal activity and positive clinical-trial news elsewhere.
- Nanobiotix closed October 20 at $24.14, up 14.52%.
- Its CFO appointment was announced October 1 and is not a new event explaining the move.